Screener
Emergent Biosolutions EBS Q1 2026 earnings
Reported April 30, 2026 · After market close
Revenue$156.1MBeat by $11.1M
EPS$0.21Beat by $0.46
Revenue estimate$145.0M
EPS estimate-$0.25
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$123.2M
EPS estimate-$0.37
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Emergent Biosolutions report Q1 2026 earnings?
- Emergent Biosolutions (EBS) reported Q1 2026 earnings on April 30, 2026 after market close.
- What were Emergent Biosolutions's Q1 2026 revenue and EPS?
- Emergent Biosolutions reported revenue of $156.1M and eps of $0.21 for Q1 2026.
- Did Emergent Biosolutions beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $145.0M by $11.1M. EPS beat the consensus estimate of $-0.25 by $0.46.
- How did Emergent Biosolutions's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 29.7% from $222.2M a year earlier and eps declined 70.4% from $0.71.
- Where can I find Emergent Biosolutions's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001367644-26-000051) and the 10-Q periodic report (0001367644-26-000065) directly on SEC EDGAR. The filing index links above go to sec.gov.
